Elevated alpha1-Antitrypsin serum levels in lung cancer patients

Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis.

Oncogene·2001

Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.

Nature genetics·2001

p53 Modulates the exonuclease activity of Werner syndrome protein.

The Journal of biological chemistry·2001

Functional interaction of p53 and BLM DNA helicase in apoptosis.

The Journal of biological chemistry·2001

p53 and K-ras mutations in lung cancers from former and never-smoking women.

Cancer research·2001

Effect of gender on the obstetric-gynecologic work force.

Obstetrics and gynecology·2001

Beyond risk factors: A capacity framework for cancer survivorship research.

Cancer·2026

Blinatumomab administration in the outpatient setting: Safety and health care utilization.

Cancer·2026

Practical considerations for the use of incretin mimetics in patients with neuroendocrine neoplasms: An expert consensus statement.

Cancer·2026

Analysis of real-world clinical outcomes of perioperative chemotherapy compared to preoperative chemoradiotherapy in esophagogastric adenocarcinoma.

Cancer·2026

Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia.

Cancer·2026

Disease-free survival as a surrogate outcome for localized kidney cancer-A systematic review and meta-analysis.

Cancer·2026

Anakinra Prophylaxis for Recurrent Severe ICANS Associated With Tarlatamab in Small Cell Lung Cancer: Case Report.

JTO clinical and research reports·2026

Prognostic value of CD103+ tumor-infiltrating lymphocytes in bladder cancer: A systematic review and meta-analysis.

Urologic oncology·2026

Immunotherapy for Glioma: A compartmental framework for resistance and rational combination design.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026

B-cells in breast cancer: current insights and challenges.

Frontiers in oncology·2026

Tumor immunosenescence drives breast cancer progression and therapeutic resistance: mechanisms and emerging interventions.

Frontiers in oncology·2026

The heterogeneous and dynamic immune-tumor interface in breast cancer.

Frontiers in oncology·2026

Related Experiment Videos

Elevated alpha1-Antitrypsin serum levels in lung cancer patients

Related Concept Videos

Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis.

Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.

p53 Modulates the exonuclease activity of Werner syndrome protein.

Functional interaction of p53 and BLM DNA helicase in apoptosis.

p53 and K-ras mutations in lung cancers from former and never-smoking women.

Effect of gender on the obstetric-gynecologic work force.

Beyond risk factors: A capacity framework for cancer survivorship research.

Blinatumomab administration in the outpatient setting: Safety and health care utilization.

Practical considerations for the use of incretin mimetics in patients with neuroendocrine neoplasms: An expert consensus statement.

Analysis of real-world clinical outcomes of perioperative chemotherapy compared to preoperative chemoradiotherapy in esophagogastric adenocarcinoma.

Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia.

Disease-free survival as a surrogate outcome for localized kidney cancer-A systematic review and meta-analysis.

Anakinra Prophylaxis for Recurrent Severe ICANS Associated With Tarlatamab in Small Cell Lung Cancer: Case Report.

Prognostic value of CD103+ tumor-infiltrating lymphocytes in bladder cancer: A systematic review and meta-analysis.

Immunotherapy for Glioma: A compartmental framework for resistance and rational combination design.

B-cells in breast cancer: current insights and challenges.

Tumor immunosenescence drives breast cancer progression and therapeutic resistance: mechanisms and emerging interventions.

The heterogeneous and dynamic immune-tumor interface in breast cancer.

Related Experiment Videos

Elevated alpha1-Antitrypsin serum levels in lung cancer patients

Related Concept Videos

Related Articles